Kazia Therapeutics (ASX:KZA) Share Price and News - StockTrack

Market Cap (15-Nov) $18,907,918 (738th)	Close (30-Jun) $0.160 0 (0%)	Volume (30-Jun) 68,980	Shortsold (1-Nov) 1 (0.00%) (657th)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.11

	Subject
	KZA KZA Ann: Change in substantial holding
	1 (current) 2 3
	KZA KZA Ann: Cleansing notice
	KZA KZA Ann: Application for quotation of securities - KZA
	KZA KZA Ann: Kazia presentation on paxalisib for childhood brain cancer
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Cleansing Notice
	KZA KZA Ann: Application for quotation of securities - KZA
	KZA KZA Ann: Kazia's paxalisib gains ODD for ATRT
	KZA KZA Ann: FDA AWARDS ORPHAN DESIGNATION TO PAXALISIB FOR ATRT
	KZA KZA Ann: Kazia paxalisib preclinical DIPG data released at IPSNO
	KZA KZA Ann: Cleansing notice
	KZA KZA Ann: Application for quotation of securities - KZA
	KZA KZA Ann: Kazia's Alliance study progresses to expansion phase
	KZA KZA Ann: Cleansing notice
	KZA KZA Ann: Proposed issue of securities - KZA
	KZA KZA Ann: Kazia presents final PII data at ASCO
	KZA KZA Ann: Application for quotation of securities - KZA
	KZA KZA Ann: Proposed issue of securities - KZA
	KZA KZA Ann: GBM Agile opens to paxalisib in Europe
	KZA KZA Ann: Cleansing notice
	KZA KZA Ann: Application for quotation of securities - KZA
	KZA KZA Ann: Notification regarding unquoted securities - KZA
	KZA KZA Ann: Kazia marks DIPG Awareness Day
	KZA KZA Ann: Application for quotation of securities - KZA
	KZA KZA Ann: Cleansing notice
	KZA KZA Ann: Notification regarding unquoted securities - KZA
	KZA KZA Ann: Application for quotation of securities - KZA
	KZA KZA Ann: Update - Proposed issue of securities - KZA
	KZA KZA Ann: Kazia to present at ASCO
	KZA KZA Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	KZA KZA Ann: Proposed issue of securities - KZA
	KZA KZA Ann: Kazia establishes ATM program
	KZA KZA Ann: Proposed issue of securities - KZA
	KZA KZA Ann: Kazia's paxalisib Phase II trial achieves completion
	KZA KZA Ann: Kazia presents preclinical data for paxalisib at AACR
	KZA KZA Ann: Kazia presents on EVT801 at AACR
	KZA KZA Ann: Kazia response to SEC comments letter
	KZA KZA Ann: Kazia to present at two conferences
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: First patient into Cornell keto study
	KZA KZA Ann: Kazia Half Year Accounts and Appx 4D
	KZA KZA Ann: Notification regarding unquoted securities - KZA
	KZA KZA Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	KZA KZA Ann: Kazia Corporate Deck
	KZA KZA Ann: Change of Director's Interest Notice
	KZA KZA Ann: Change of Director's Interest Notice * 3
	KZA KZA Ann: Change in substantial holding
	KZA KZA Ann: Issue of shares
	KZA KZA Ann: Kazia appoints Karen Krumeich as CFO
	KZA KZA Ann: Kazia releases final data from P2 paxalisib trial

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
15-Nov	$0.08	0	0.00 (0.00%)
14-Nov	$0.08	0	0.00 (0.00%)
13-Nov	$0.08	454,181	+0.01 (9.59%)
10-Nov	$0.07	1,958,419	-0.01 (16.09%)
09-Nov	$0.09	2,428,685	-0.02 (20.91%)
08-Nov	$0.11	1,035,042	+0.03 (37.50%)
07-Nov	$0.08	489,091	+0.01 (19.40%)
06-Nov	$0.07	1,622,414	+0.01 (21.82%)
03-Nov	$0.06	938,181	0.00 (0.00%)
02-Nov	$0.06	1,610,003	-0.01 (9.84%)
01-Nov	$0.06	742,258	-0.01 (12.86%)
31-Oct	$0.07	1,267,882	-0.01 (12.50%)
30-Oct	$0.08	732,079	-0.01 (5.88%)
27-Oct	$0.09	596,210	0.00 (4.49%)
26-Oct	$0.09	399,238	0.00 (1.11%)
4 up, 8 down, and 3 flat days

High $0.16	Low $0.16	Trades 13	Turnover $11,013	Volume 68,980
30 June 2023 at 12:18pm

High $0.16	Low $0.16	Trades 13	Turnover $11,013	Volume 68,980
30 June 2023 at 12:18pm

Kazia Therapeutics Health Care
Cancer Medical

$0.160 -0.005 (-3.03%)

$0.160 -0.005 (-3.03%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

KZA Kazia Therapeutics Health Care Cancer Medical

$0.160 -0.005 (-3.03%)

$0.160 -0.005 (-3.03%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Kazia Therapeutics Health Care
Cancer Medical